Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Divestments (2020 - 2021)

Historic Divestments for Standard Biotools (LAB) over the last 2 years, with Q4 2021 value amounting to -$682000.0.

  • Standard Biotools' Divestments fell 10689.93% to -$682000.0 in Q4 2021 from the same period last year, while for Sep 2022 it was -$682000.0, marking a year-over-year decrease of 10573.83%. This contributed to the annual value of $1.3 million for FY2021, which is 9373.46% down from last year.
  • Latest data reveals that Standard Biotools reported Divestments of -$682000.0 as of Q4 2021, which was down 10689.93% from $2.0 million recorded in Q1 2021.
  • Standard Biotools' 5-year Divestments high stood at $11.2 million for Q3 2020, and its period low was -$682000.0 during Q4 2021.